icometrix
Belgium - LeuvenBiotechnology
Focus: icometrix is an imaging AI specialist focused on quantitative MRI and clinical decision-support platforms for neurological conditions, particularly multiple sclerosis and traumatic brain injury. The company operates as a public-stage biotech based in Leuven, Belgium, with a tightly focused pipeline of software and imaging solutions rather than traditional small-molecule or biologic drugs.
Profile data last refreshed 13h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About icometrix
AI assessmentNot HiringNo open roles listed right now. Follow icometrix to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from icometrix's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
icompanion app
Multiple SclerosisMS Care Platform
Relapsing Remitting Multiple Sclerosisquantitative brain MRI
Help build intelligence for icometrix
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.